The of the National Vaccine Advisory Committee, NVAC) has sought broad public input into the scientific research agenda that is being developed by the Centers for Disease Control and Prevention's (CDC) Immunization Safety Office (ISO).
At its , the NVAC Vaccine Safety Working Group discussed outcomes and issues highlighted in three public engagement sessions held earlier in Birmingham, Alabama; Ashland, Oregon; and Indianapolis, Indiana. A summary of the written comments sent to HHS on the CDC ISO research agenda was also discussed.
- View the archived Webcast - 270 minutes.
[RealPlayer is required to view the Webcast.]
For brief comments from the community representatives at the conclusion of the NVAC Vaccine Safety Working Group meeting, select the video links below.
They briefly discussed why they attended the recent community meetings, what they learned from their experiences, and what they hope will be the outcome of the public engagement project on vaccine safety.
The Working Group Chair, Dr. Andy Pavia, also offered comments after the meeting.
 |
Tracy Cron, Birmingham, AL - 1:47 minutes |
 |
Toni DiLeo, Ashland, OR - 2:23 minutes |
 |
Bernard Richard, Indianapolis, IN - 2:12 minutes |
 |
Andy Pavia, MD, Chair, NVAC Vaccine Safety Working Group - 1:24 minutes |
